Evidence map›Paper›PMID 35547018›Full record

Review3 Biotech2022

Recent advances in microbial co-culture for production of value-added compounds.

Nguyen Huy Thuan, Vinay Bharadwaj Tatipamula, Nguyen Xuan Canh, Nguyen Van Giang

Abstract readReview
In one paragraph

Review in 3 Biotech, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Nguyen Huy ThuanCenter for Molecular Biology, Duy Tan University, Da Nang, 550000 Vietnam.ORCID 0000-0001-8891-7195
Vinay Bharadwaj TatipamulaCenter for Molecular Biology, Duy Tan University, Da Nang, 550000 Vietnam.ORCID 0000-0002-9376-1911
Nguyen Xuan CanhFaculty of Biotechnology, Vietnam National University of Agriculture, Gialam, Hanoi Vietnam.ORCID 0000-0002-7791-6397
Nguyen Van GiangFaculty of Biotechnology, Vietnam National University of Agriculture, Gialam, Hanoi Vietnam.ORCID 0000-0003-3044-7383

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Micro-organisms have often been used to produce bioactive compounds as antibiotics, antifungals, and anti-tumors, etc. due to their easy and applicable culture, genetic manipulation, and extraction, etc. Mainly, microbial mono-cultures have been applied to produce value-added compounds and gotten numerous valuable results. However, mono-culture also has several complicated problems, such as metabolic burdens affecting the growth and development of the host, leading to a decrease in titer of the target compound. To circumvent those limitations, microbial co-culture has been technically developed and gained much interest compared to mono-culture. For example, co-culture simplifies the design of artificial biosynthetic pathways and restricts the recombinant host's metabolic burden, causing increased titer of desired compounds. This paper summarizes the recent advanced progress in applying microbial platform co-culture to produce natural products, such as flavonoid, terpenoid, alkaloid, etc. Furthermore, importantly different strategies for enhancing production, overcoming the metabolic burdens, building autonomous modulation of cell growth rate and culture composition in response to a quorum-sensing signal, etc., were also described in detail.

Indexed as

Biosynthetic productionCo-cultureMetabolic engineeringNatural product

Identifiers

PMID35547018
PMCPMC9018925

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.